10.06.2024 08:02:05 - dpa-AFX: *GSK: FDA APPROVES EXPANDED AGE INDICATION FOR AREXVY, THE FIRST RSV VACCINE FOR ADULTS AGED 50-59

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH